Hey Arkansas! This info might be of some use to you in defending the insane notion there is no Lyme disease in your state. Feel free to use any or all of it. Hoping it will be of some help. Good luck! Lucy Barnes
~ ~ ~
In 2012 Maria Theresa Montales (lead author on article below) from the Arkansas Children's Nutrition Center published her first study on breast cancer in mice showing improvement with soybeans and blueberries.
Naveen Patil, from the Arkansas Department of Health, later published with MT Montales on tuberculosis (TB) in a pregnant cystic fibrosis patient.
Montales and Patil then partenered up with Beebe & Chaudhury and published on TB in an HIV patient. This group later added on S. Patil (related to N. Patil?) and published again on HIV & TB.
Five months later the above group added on Haselow, Weinstein and Taffner and published their latest article below claiming there is no Lyme disease in the state of Arkansas.
Haselow published last on the 2012 drought in the USA and its affects on home owners private wells (an analysis) and nothing on Lyme disease.
Weinstein published on the loss of chromosone Y, poorly controled asthma, telomere length related to B-cell lymphoma and lukemia, but nothing on Lyme disease.
None of them have ever published on Lyme disease prior to this except for N. Patil (health department) who published a clinical review of Lyme in Arkansas in 2010. (Abstract below.) AND... none of Patil's co-authors on the 2010 review ever published on Lyme disease before or since.
J Ark Med Soc. 2016 May;112(13):254-8.
A Clinical Review of Tick-Borne Diseases in Arkansas.
Tick-borne diseases are illnesses transmitted by ticks harboring wide variety of pathogens. Arkansas is reported as one of the states with a high incidence of tick-borne diseases.
In Arkansas the four most frequently occurring tick-borne diseases are Rocky Mountain Spotted Fever (RMSF, also known as Spotted Fever Rickettsiosis), Ehrlichiosis, Tularemia and Anaplasmosis.
Lyme disease, on the other hand, is not acquired in Arkansas and is only acquired by traveling to states where Lyme disease is endemic.
The majority of tick-borne diseases are diagnosed based on a history of tick bite or exposure and the individual's clinical presentation.
The recognition of specific symptoms requires prompt treatment to prevent long-term sequelae. Hence, knowledge of tick-borne diseases and preventive measures can help reduce the risks associated with the infection.
PMID: 27263175 [PubMed - in process]
Link Here- http://www.ncbi.nlm.nih.gov/pubmed/27263175
J Ark Med Soc. 2010 Feb;106(8):186-8.
A clinical review of Lyme disease in Arkansas.
Lyme disease is the most common tick-borne disease in the northern hemisphere. Since it was first described more than 30 years ago, Lyme disease has generated a great deal of controversy.
Lyme disease is not endemic in Arkansas, and testing for Borrelia burgdorferi can lead to clinical confusion, unnecessary treatment and excess cost.
This article will present a brief review of Lyme disease, with an emphasis on what is known regarding Lyme disease in Arkansas.
J Community Health. 2015 Apr;40(2):339-46. doi: 10.1007/s10900-014-9940-9.
Provider knowledge, attitudes, and practices regarding Lyme disease in Arkansas.
Lyme disease (LD), a vector-borne disease, causes illness for many individuals in the United States.
All of the conditions for the promulgation of LD are present in one Southern state in the United States; yet this state reports lower numbers of LD than adjacent states.
The purpose of this study was to determine associations between this Southern state's primary care providers' knowledge and attitudes regarding the diagnosis and reporting of LD.
A quantitative, cross-sectional study was conducted via a mailed questionnaire by the Arkansas Department of Health to 2,693 primary care providers.
Respondents were 660 primary care providers from all regions of this state. Secondary data were analyzed using descriptive, Chi square, and logistic regression techniques.
Analysis results included the following: a correct response rate of 59.1 % for symptom recognition, of 46.2 % for knowledge of recommended testing processes, and of 78.9 % for knowing LD is a reportable disease.
These results compared to the expected norm were significant in every area with p values of .000.
Specialty, region, and years of practice were found to be confounding influences in a number of assessment areas.
PMID: 25187225 [PubMed - indexed for MEDLINE]
Link Here- http://www.ncbi.nlm.nih.gov/pubmed/25187225
Additional comments and info here at LymeNet